RESUMEN
Background: induction of labor is a common obstetric procedure which is performed for a variety of medical and non-medical indications. If the cervix is unfavourable, prior ripening of the cervix makes induction of labor easier and more succeful. There are different methods for ripening of the cervix and making it ready for induction. These methods included medical methods such as the administration of prostaglandins, and mechanical methods such as extra amniotic saline infusion, traction on the cervix with Foley catheter and laminaria
Aim of the Work: the aim of the study is to evaluate the efficacy of intramuscular dexamethazone injection prior to induction in improving progression and duration of labour phases
Patients and Methods: this study started with 100 Nulliparous Pregnant women who were conducted at the labor wards of Ain Shams Maternity Hospital. The studied subjects were randomized into two groups: Dexamethasone group: This group included 50 Nulliparous women [N=50], called A group. Control group: This group included 50 Nulliparous woman [N=50], called B group
Results: in this study the duration of active and second stages was decreased without change on mode of delivery. The study no significant statistical differences between the two studied groups as regards fetal heart rate. The duration of second stage in dexamethasone group was shorter than in the control group. Dexamethasone intramuscularly prior to induction significantly shortens duration of normal labor in normal parturants with minimal complications
Conclusion: an intramuscular injection of dexamethasone before labor induction is found to shorten the duration of labor induction by decreasing the interval between the initiation of induction and the beginning of the active phase, duration of active phase and duration of second stage of labor with no observed maternal or neonatal complications
RESUMEN
Background: vascular endothelial growth factor and placental growth factor levels were significantly lower in patients of sever or early onset [34 weeks or less gestational age at onset of PET] pre-eclampsia than in controls
Aim of the Work: will there be a rise in serum vascular endothelial growth factor in pregnant women suffering from preeclampsia than in normotensive pregnant women
Patients and Methods: 150 pregnant women from 28 weeks of gestation till term will be enrolled into this comparative clinical trial at the time of their antenatal visit to the outpatient department of obstetrics and gynecology Ain Shams University maternal hospital
Results: we recruited 150 pregnant women after 28 weeks of gestation and they were classified into 3 groups: Group1:50 pregnant women with mild preeclampsia from 28 weeks of gestation till term, Group2: 50 pregnant women with severe preeclampsia from 28 weeks of gestation till term and Group 3: 50 normal pregnant women serving as controls
Conclusion: We conclude that serum VEGF level measured after 28 weeks of gestation can be used as a predictor for preeclampsia and its degrees [mild and severe] with high sensitivity and specificity